Molecular targeted therapy: Treating cancer with specificity
Top Cited Papers
- 20 July 2018
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 834, 188-196
- https://doi.org/10.1016/j.ejphar.2018.07.034
Abstract
No abstract availableKeywords
Funding Information
- University of Salford Manchester
This publication has 82 references indexed in Scilit:
- Advances in the proteomic discovery of novel therapeutic targets in cancerDrug Design, Development and Therapy, 2013
- Therapeutic Cancer VaccinesClinical Journal of Sport Medicine, 2012
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesMolecular Oncology, 2012
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastomaNeuro-Oncology, 2010
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed GlioblastomaJournal of Clinical Oncology, 2010
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2010
- Monoclonal antibodies: versatile platforms for cancer immunotherapyNature Reviews Immunology, 2010
- Mechanisms of Resistance to Anti-Angiogenic Therapy and Development of Third-Generation Anti-Angiogenic Drug CandidatesGenes & Cancer, 2010
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008